TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma. (Q34775855)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma. |
scientific article |
Statements
TP53 oncomorphic mutations predict resistance to platinum‑ and taxane‑based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma (English)
Pavla Brachova
Matthew J Carlson
Michael J Goodheart
Anna M Button
Sarah L Mott
Donghai Dai
Kristina W Thiel
11 November 2014
1 reference
1 reference
1 reference
1 reference